Rotavirus Vaccines: Targeting the Developing World
Open Access
- 1 September 2005
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 192 (s1) , S160-S166
Abstract
For the past 2 decades, rotavirus infection, the most common cause of severe diarrhea in children, has been a priority target for vaccine developmentKeywords
This publication has 28 references indexed in Scilit:
- Anticipating rotavirus vaccines: epidemiology and surveillance of rotavirus in South AfricaVaccine, 2003
- Intussusception among Infants Given an Oral Rotavirus VaccineNew England Journal of Medicine, 2001
- Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries1Prepared as a review for the Consensus Workshop on Rotavirus Vaccines for use in Developing Countries, Geneva, January 9–10, 1997. Sponsored by: The Global Programme for Vaccines, World Health Organization, The Children's Vaccine Initiative and the Centers for Disease Control and Prevention.1Vaccine, 1999
- Efficacy of the Rhesus Rotavirus–Based Quadrivalent Vaccine in Infants and Young Children in VenezuelaNew England Journal of Medicine, 1997
- Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritisThe Lancet, 1997
- Rotavirus Infection in Infants as Protection against Subsequent InfectionsNew England Journal of Medicine, 1996
- Trends of diarrheal disease--associated mortality in US children, 1968 through 19911995
- TRIAL OF AN ATTENUATED BOVINE ROTAVIRUS VACCINE (RIT 4237) IN GAMBIAN INFANTSThe Lancet, 1987
- FAILURE OF LIVE, ATTENUATED ORAL ROTAVIRUS VACCINEThe Lancet, 1986
- PROTECTION OF INFANTS AGAINST ROTAVIRUS DIARRHOEA BY RIT 4237 ATTENUATED BOVINE ROTAVIRUS STRAIN VACCINEThe Lancet, 1984